SCHEMBL394175

SCHEMBL394175

CCSC(=O)OCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23748438 0.81
SCHEMBL3286933 0.79
SCHEMBL7066310 0.78 ACHE (0.50)
SCHEMBL15300932 0.77
SCHEMBL14721793 0.75
SCHEMBL21638952 0.75
SCHEMBL1507150 0.75
SCHEMBL13347314 0.74
SCHEMBL19136728 0.73
SCHEMBL19142615 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240190875-A1 SPIROINDOLINE DERIVATIVE, AND PREPARATION METHOD AND MEDICAL USE THEREOF CHANGCHUN GENESCIENCE PHARMACEUTICAL CO., LTD. (CN) 2024-06-13 US disclosed
EP-4364727-A2 ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF Teon Therapeutics, Inc. (US) 2024-05-08 EP disclosed
CN-112920092-B Prodrugs of glutamine analogues 约翰霍普金斯大学 2024-04-26 CN disclosed
US-11926640-B2 Prodrugs of glutamine analogs THE JOHNS HOPKINS UNIVERSITY (US) 2024-03-12 US disclosed
EP-3762386-B1 ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF TEON THERAPEUTICS INC (US) 2024-01-24 EP disclosed
EP-3762386-B1 ADENOSINE RECEPTOR ANTAGONISTS AND USES THEREOF TEON THERAPEUTICS INC (US) 2024-01-24 EP disclosed
CN-117157295-A Indoline-containing spiro derivative, preparation method and medical application thereof 长春金赛药业有限责任公司 2023-12-01 CN disclosed
EP-4282867-A1 INDOLINE-CONTAINING SPIRO DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2023-11-29 EP disclosed
EP-4282867-A1 INDOLINE-CONTAINING SPIRO DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2023-11-29 EP disclosed
US-20230279025-A1 KRAS G12D INHIBITORS ARRAY BIOPHARMA INC. 2023-09-07 US disclosed
WO-2005028473-A1 ACYLOXYMETHYLCARBAMATE PRODRUGS OF OXAZOLIDINONES PHARMACIA & UPJOHN COMPANY LLC (US) 2005-03-31 WO disclosed
WO-2005009944-A1 PRODRUGS OF 9-AMINOMETHYL TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. (US) 2005-02-03 WO disclosed
US-20050014787-A1 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed
EP-1443041-A1 5-AMIDINO-2-HYDROXYBENZENESULFONAMIDE DERIVATIVES, MEDICINAL COMPOSITIONS CONTAINING THE SAME, MEDICINAL USE THEREOF AND INTERMEDIATES IN THE PRODUCTION THEREOF Kissei Pharmaceutical Co., Ltd. (JP) 2004-08-04 EP disclosed
WO-2004009068-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY AND MEDICINES CONTAINING SAME CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2004-01-29 WO disclosed
WO-2001056358-A2 ENHANCED PROPERTIED PESTICIDES ROHM AND HAAS COMPANY (US) 2001-08-09 WO disclosed
EP-0629214-B1 CHEMICAL COMPOUNDS NYCOMED IMAGING AS (NO) 1996-10-23 EP disclosed
EP-0627942-A1 IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS NYCOMED IMAGING AS (NO) 1994-12-14 EP disclosed
CN-1084410-A Relate to the improvement of contrast agent NYCOMED IMAGING AS (NO) 1994-03-30 CN disclosed
WO-1993017718-A1 IMPROVEMENTS IN OR RELATING TO CONTRAST AGENTS NYCOMED IMAGING A/S (NO) 1993-09-16 WO disclosed